Aurisco Pharmaceutical Co Ltd Total Liabilities

Latest as of June 2025: CN¥1.47 Billion CNY ≈ $215.58 Million USD

Aurisco Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Aurisco Pharmaceutical Co Ltd (605116) has total liabilities worth CN¥1.47 Billion CNY (≈ $215.58 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Aurisco Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Aurisco Pharmaceutical Co Ltd (2016–2024)

Total liabilities of Aurisco Pharmaceutical Co Ltd from 2016 to 2024. This chart illustrates how Aurisco Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

Aurisco Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Aurisco Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Giant Manufacturing Co Ltd TW:9921	Taiwan	NT$33.80 Billion
Bristow Group Inc NYSE:VTOL	USA	$1.35 Billion
Hisense Home Appliances Group Co. Ltd F:GKE	Germany	€52.36 Billion
Hunan Keli Motor Co Ltd SHE:002892	China	CN¥1.50 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥82.76 Million
Alma Media Oyj HE:ALMA	Finland	€271.90 Million
Bank Islam Malaysia Bhd KLSE:5258	Malaysia	RM94.68 Billion
Hunan Oil Pump SHG:603319	China	CN¥1.72 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Aurisco Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 605116 total assets.

Liquidity & Leverage Metrics

Aurisco Pharmaceutical Co Ltd Total Liabilities Ratios Explained

Aurisco Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.51	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aurisco Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aurisco Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Aurisco Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.55 Billion ≈ $226.21 Million	+154.67%
2023-12-31	CN¥607.03 Million ≈ $88.83 Million	+74.09%
2022-12-31	CN¥348.68 Million ≈ $51.02 Million	+63.37%
2021-12-31	CN¥213.44 Million ≈ $31.23 Million	+44.23%
2020-12-31	CN¥147.98 Million ≈ $21.65 Million	+20.34%
2019-12-31	CN¥122.96 Million ≈ $17.99 Million	-7.65%
2018-12-31	CN¥133.16 Million ≈ $19.48 Million	+0.54%
2017-12-31	CN¥132.44 Million ≈ $19.38 Million	-31.03%
2016-12-31	CN¥192.01 Million ≈ $28.10 Million	--

About Aurisco Pharmaceutical Co Ltd

SHG:605116 China Biotechnology

Market Cap

$1.11 Billion

CN¥7.56 Billion CNY

Market Cap Rank

#8168 Global

#1843 in China

Share Price

CN¥18.60

Change (1 day)

-0.96%

52-Week Range

CN¥17.46 - CN¥34.43

All Time High

CN¥34.43